Literature DB >> 29696346

Orthostatic intolerance and postural tachycardia syndrome: new insights into pathophysiology and treatment.

Mohammed Ruzieh1, Blair P Grubb2.   

Abstract

Orthostatic intolerance is characterized by symptoms of light-headedness or syncope that is provoked upon standing or in an upright posture. It is most commonly caused by postural orthostatic tachycardia syndrome (POTS) or orthostatic hypotension (OH). Its pathophysiology is complex and commonly involves abnormal autonomic nervous system regulation, autoimmunity, a hyperadrenergic state, and hypovolemia. This article reviews the pathophysiology underlying orthostatic intolerance, as well as the current treatment available.

Entities:  

Keywords:  Autoimmunity; Hypovolemia; Orthostatic hypotension; Pathophysiology; Postural tachycardia syndrome

Mesh:

Year:  2018        PMID: 29696346     DOI: 10.1007/s00399-018-0563-1

Source DB:  PubMed          Journal:  Herzschrittmacherther Elektrophysiol        ISSN: 0938-7412


  32 in total

Review 1.  Postural tachycardia syndrome (POTS).

Authors:  Satish R Raj
Journal:  Circulation       Date:  2013-06-11       Impact factor: 29.690

2.  Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies.

Authors:  S Vernino; P A Low; R D Fealey; J D Stewart; G Farrugia; V A Lennon
Journal:  N Engl J Med       Date:  2000-09-21       Impact factor: 91.245

3.  Sympathotonic orthostatic hypotension: a report of four cases.

Authors:  R D Hoeldtke; G E Dworkin; S R Gaspar; B C Israel
Journal:  Neurology       Date:  1989-01       Impact factor: 9.910

4.  ACC/AHA Guidelines for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices: Executive Summary--a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Pacemaker Implantation).

Authors:  G Gregoratos; M D Cheitlin; A Conill; A E Epstein; C Fellows; T B Ferguson; R A Freedman; M A Hlatky; G V Naccarelli; S Saksena; R C Schlant; M J Silka
Journal:  Circulation       Date:  1998-04-07       Impact factor: 29.690

5.  2015 heart rhythm society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope.

Authors:  Robert S Sheldon; Blair P Grubb; Brian Olshansky; Win-Kuang Shen; Hugh Calkins; Michele Brignole; Satish R Raj; Andrew D Krahn; Carlos A Morillo; Julian M Stewart; Richard Sutton; Paola Sandroni; Karen J Friday; Denise Tessariol Hachul; Mitchell I Cohen; Dennis H Lau; Kenneth A Mayuga; Jeffrey P Moak; Roopinder K Sandhu; Khalil Kanjwal
Journal:  Heart Rhythm       Date:  2015-05-14       Impact factor: 6.343

Review 6.  Syndromes of orthostatic intolerance: a hidden danger.

Authors:  A Fedorowski; O Melander
Journal:  J Intern Med       Date:  2013-04       Impact factor: 8.989

7.  Orthostatic intolerance and tachycardia associated with norepinephrine-transporter deficiency.

Authors:  J R Shannon; N L Flattem; J Jordan; G Jacob; B K Black; I Biaggioni; R D Blakely; D Robertson
Journal:  N Engl J Med       Date:  2000-02-24       Impact factor: 91.245

8.  Abnormal norepinephrine clearance and adrenergic receptor sensitivity in idiopathic orthostatic intolerance.

Authors:  G Jacob; J R Shannon; F Costa; R Furlan; I Biaggioni; R Mosqueda-Garcia; R M Robertson; D Robertson
Journal:  Circulation       Date:  1999-04-06       Impact factor: 29.690

9.  Antibody titers predict clinical features of autoimmune autonomic ganglionopathy.

Authors:  Christopher H Gibbons; Roy Freeman
Journal:  Auton Neurosci       Date:  2009-01-13       Impact factor: 3.145

10.  Effects of meal composition on the postprandial blood pressure, catecholamine and insulin changes in elderly subjects.

Authors:  J F Potter; D Heseltine; G Hartley; J Matthews; I A MacDonald; O F James
Journal:  Clin Sci (Lond)       Date:  1989-09       Impact factor: 6.124

View more
  1 in total

1.  Editorial: Autonomic Neuropathy and Cardiovascular Disease in Aging.

Authors:  A Shams; J E Morley
Journal:  J Nutr Health Aging       Date:  2018       Impact factor: 4.075

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.